Is Goldman Sachs Right About Selling Boeing?
Shares of Boeing dropped more than 3% at one point Monday morning following a downgrade from Neutral to Sell by analysts at Goldman Sachs.
Archive
Year: 2015
All Year: 2015 Articles
Newest first · Page 487What Exxon Reserves Replacement Numbers Really Mean
Exxon Mobil reported Monday morning that it had replaced 104% of the hydrocarbons it produced in 2014.
Can Ocwen Turn Itself Around With This Sale?
Ocwen Financial has announced the sale of residential servicing rights on a portfolio consisting of roughly 81,000 performing loans to Nationstar Mortgage Holdings.
Texas Business and Manufacturing Suffers Further From Low Oil Prices
The Federal Reserve Bank of Dallas has released its Texas Manufacturing Outlook Survey for the month of February.
Why Warren Buffett Wants to Own the Credit Card Space
Owning a piece of the credit card industry has turned out to be a very lucrative business for those investors who have had a long-term eye on the sector.
January Sales of Existing Homes Slide to 9-Month Low
The National Association of Realtors reports that the seasonally adjusted annual rate of existing home sales in January dropped to its the lowest since April 2014.
Will New Darden CEO Turn Olive Garden Around?
Darden Restaurants Inc. (NYSE: DRI) announced Monday morning that interim CEO Eugene Lee has been permanently appointed to the role.
UBS Has 3 Must-Own Cybersecurity Software Stocks
UBS analysts are focused on these three top companies to buy in the cybersecurity space. Despite some large upside moves, the analysts feel comfortable more upside lies ahead.
Target Lowers Free Shipping Threshold to $25
In a move that is surely designed to attract more shoppers to its online and mobile offerings, Target has lowered its free shipping threshold to $25.
Is Rigel Getting Enough From Bristol-Meyers?
Rigel Pharmaceuticals and Bristol-Myers Squibb announced Monday morning that they have entered into a collaboration agreement.
Jefferies 4 Top Pharmaceutical Stocks to Buy
One area that makes sense for growth investors is the large cap pharmaceuticals. Here are some the top pharmaceutical stocks to buy now according to Jefferies.
Top Analyst Upgrades and Downgrades: Arch Coal, Boeing, CSX, DirecTV, LabCorp and More
Monday's top analyst upgrades, downgrades and initiations include Arch Coal, Boeing, CSX, DirecTV and LabCorp.
Dish Network Revenues Rise as Subscribers Fade Away
Dish Network reported better-than-expected fourth-quarter and full-year 2014 earnings before markets opened Monday morning.
5 Energy Buyout Candidates as Oil Plunge Continues
RBC Capital Markets has prepared a massive list of companies that could be takeout candidates. The firm sees these energy stocks as potentially a good fit for an acquirer.
3M and Japanese Firm Each Get a Piece of Polypore
Immediately prior to Polypore International's merger with Asahi Kasei, 3M will pay Asahi Kasei approximately $1 billion to acquire Polypore’s separations media business.